Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SymBio Pharmaceuticals
company
About
SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥2B
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Mar 1, 2005
- Number Of Employee
- 51 - 100
- Operating Status
- Active
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥2.55B
SymBio Pharmaceuticals has raised a total of
¥2.55B
in funding over 2 rounds. Their latest funding was raised on
May 10, 2010 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 10, 2010 | Series Unknown | ¥550.20M | 1 | — | — | Detail |
| Jun 27, 2006 | Series B | ¥2B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
SymBio Pharmaceuticals is funded by 2 investors.
JAFCO Group
and TNP Threads Of Light
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
TNP Threads Of Light
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
